The Transdermal Drug market is a subset of the Transdermal and Transmucosal Drug Delivery market. Transdermal drug delivery is a method of delivering drugs through the skin, allowing for systemic absorption of the drug. This method of drug delivery is advantageous because it avoids the first-pass metabolism of the drug, which can reduce the amount of drug available for systemic absorption. Transdermal drug delivery also offers the potential for sustained drug release, allowing for more consistent drug levels in the body. The Transdermal Drug market is composed of a variety of companies that specialize in the development and manufacture of transdermal drug delivery systems. These companies include 3M Drug Delivery Systems, Acrux, Alza Corporation, BioDelivery Sciences International, Inc., Endo Pharmaceuticals, Inc., and Mylan Pharmaceuticals, Inc. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
